| Management of Graves’ ophthalmopathy: reality and perspectives L Bartalena, A Pinchera, C Marcocci Endocrine reviews 21 (2), 168-199, 2000 | 985 | 2000 |
| Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy L Bartalena, C Marcocci, F Bogazzi, L Manetti, ML Tanda, E Dell'Unto, ... New England Journal of Medicine 338 (2), 73-78, 1998 | 943 | 1998 |
| The 2016 European Thyroid Association/European Group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy L Bartalena, L Baldeschi, K Boboridis, A Eckstein, GJ Kahaly, C Marcocci, ... European thyroid journal 5 (1), 9-26, 2016 | 843 | 2016 |
| The effects of amiodarone on the thyroid E Martino, L Bartalena, F Bogazzi, LE Braverman Endocrine reviews 22 (2), 240-254, 2001 | 809 | 2001 |
| Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO L Bartalena, L Baldeschi, A Dickinson, A Eckstein, P Kendall-Taylor, ... European journal of endocrinology 158 (3), 273-285, 2008 | 791 | 2008 |
| Selenium and the course of mild Graves' orbitopathy C Marcocci, GJ Kahaly, GE Krassas, L Bartalena, M Prummel, M Stahl, ... New England Journal of Medicine 364 (20), 1920-1931, 2011 | 637 | 2011 |
| 2018 European Thyroid Association guideline for the management of Graves’ hyperthyroidism GJ Kahaly, L Bartalena, L Hegedüs, L Leenhardt, K Poppe, SH Pearce European thyroid journal 7 (4), 167-186, 2018 | 613 | 2018 |
| Epidemiology and prevention of Graves' ophthalmopathy WM Wiersinga, L Bartalena Thyroid 12 (10), 855-860, 2002 | 577 | 2002 |
| Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy L Bartalena, L Baldeschi, AJ Dickinson, A Eckstein, P Kendall-Taylor, ... Thyroid 18 (3), 333-346, 2008 | 556 | 2008 |
| Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves’ ophthalmopathy … C Marcocci, L Bartalena, ML Tanda, L Manetti, E Dell’Unto, R Rocchi, ... The Journal of Clinical Endocrinology & Metabolism 86 (8), 3562-3567, 2001 | 417 | 2001 |
| Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism L Bartalena, C Marcocci, F Bogazzi, M Panicucci, A Lepri, A Pinchera New England Journal of Medicine 321 (20), 1349-1352, 1989 | 394 | 1989 |
| Graves' ophthalmopathy L Bartalena, ML Tanda New England Journal of Medicine 360 (10), 994-1001, 2009 | 378 | 2009 |
| Cigarette smoking and treatment outcomes in Graves ophthalmopathy L Bartalena, C Marcocci, ML Tanda, L Manetti, E Dell'Unto, MP Bartolomei, ... Annals of internal medicine 129 (8), 632-635, 1998 | 375 | 1998 |
| Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone L Bartalena, C Marcocci, L Chiovato, M Laddaga, G Lepri, D Andreani, ... The Journal of Clinical Endocrinology & Metabolism 56 (6), 1139-1144, 1983 | 342 | 1983 |
| Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study L Bartalena, S Brogioni, L Grasso, F Bogazzi, A Burelli, E Martino The Journal of Clinical Endocrinology & Metabolism 81 (8), 2930-2933, 1996 | 325 | 1996 |
| The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism B Biondi, L Bartalena, DS Cooper, L Hegedüs, P Laurberg, GJ Kahaly European thyroid journal 4 (3), 149-163, 2015 | 317 | 2015 |
| Complex alteration of thyroid function in healthy centenarians S Mariotti, G Barbesino, P Caturegli, L Bartalena, P Sansoni, F Fagnoni, ... The Journal of Clinical Endocrinology & Metabolism 77 (5), 1130-1134, 1993 | 302 | 1993 |
| Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center ML Tanda, E Piantanida, L Liparulo, G Veronesi, A Lai, L Sassi, N Pariani, ... The Journal of Clinical Endocrinology & Metabolism 98 (4), 1443-1449, 2013 | 289 | 2013 |
| Diagnosis and management of Graves disease: a global overview L Bartalena Nature Reviews Endocrinology 9 (12), 724-734, 2013 | 282 | 2013 |
| Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy L Bartalena, GE Krassas, W Wiersinga, C Marcocci, M Salvi, C Daumerie, ... The Journal of Clinical Endocrinology & Metabolism 97 (12), 4454-4463, 2012 | 274 | 2012 |
